Jiangsu Nanfang Medical Hits Day Low at CNY 6.25 Amid Price Pressure

Jiangsu Nanfang Medical Co., Ltd. experienced significant volatility on July 17, 2026, with the stock declining by 8.36% and reaching an intraday low of CNY 6.25. This performance stands in contrast to the broader market, as the China Shanghai Composite index fell by 3.05% on the same day. Over the past week, Jiangsu Nanfang Medical has seen a decline of 10.42%, while its monthly performance reflects a more substantial drop of 21.09%. Year-to-date, the stock has managed a modest gain of 2.09%, but this is overshadowed by a 5.64% decline over the past five years. The company's market capitalization is currently CNY 2,242 million, categorizing it as a small-cap entity within the pharmaceuticals and biotechnology sector. Financial metrics indicate challenges, with a debt-to-equity ratio of 2.25 and a return on equity of -57.03%. The company has reported a net profit loss of CNY 24.93 million for the first nine months, reflecting a significant decline of 87.25%. These factors contribute to a complex financial landscape for Jiangsu Nanfang Medical as it navigates current market conditions.